Biological Diversity Act 2002

Biological Diversity Act 2002 (BDA 2002) is India’s principal statute governing the access to biological resources and the equitable sharing of benefits arising from their use. Enacted to fulfill obligations under the 1992 Convention on Biological Diversity (CBD), the Act uniquely blends conservation, sustainable use, and the protection of traditional knowledge within a single legal framework, making it a cornerstone of the country’s biodiversity policy.

Origins and Legislative Context

The BDA 2002 was passed by Parliament on 12 May 2002 and came into force on 18 May 2003, three years after India ratified the CBD on 2 December 1994. Its legislative history traces back to the 1997 National Biodiversity Strategy and Action Plan, which highlighted the need for a domestic law to regulate bioprospecting and prevent biopiracy. The Act was introduced in the Lok Sabha by then‑Environment Minister Jairam Ramesh, who emphasized that “our rich flora and fauna must be safeguarded while enabling scientific research.” The statute reflects Article 2 of the Indian Constitution, which directs the State to protect and improve the environment, and it aligns with the 2000 National Biodiversity Authority (NBA) Ordinance that preceded the formal Act.

Institutional Framework

Section 3 of the Act establishes the National Biodiversity Authority (NBA) as an autonomous body under the Ministry of Environment, Forest and Climate Change, chaired by the Secretary‑Environment and comprising ten members appointed by the President. The NBA’s mandate includes granting permission for the commercial use of biological resources, monitoring benefit‑sharing agreements, and maintaining the National Biodiversity Database. Complementing the NBA, Section 4 creates State Biodiversity Boards (SBBs) in each of the 28 states and 8 union territories; as of 2023, all states have operational SBBs chaired by the respective Chief Secretary. At the grassroots level, Section 5 mandates the formation of Biodiversity Management Committees (BMCs) in every gram panchayat, each consisting of at least five members, to document local species and oversee community‑level benefit sharing.

Core Provisions

The Act’s Section 6 requires any person or entity seeking access to biological resources to obtain prior informed consent (PIC) from the NBA and to negotiate a mutually agreed term (MAT) that specifies benefit‑sharing ratios. Section 7 empowers the NBA to levy a royalty of up to 5 percent on commercial products derived from Indian genetic material, a figure that has been applied in cases involving neem‑based pesticides and turmeric extracts. Section 9 protects traditional knowledge by prohibiting the patenting of any invention that is already documented in the Traditional Knowledge Digital Library (TKDL), a repository launched in 2001 and updated under the Act’s provisions. The Act also criminalises the unauthorized collection of biological material, prescribing fines up to ₹5 lakh and imprisonment for up to three years under Section 12.

Implementation and Current Status

Since its inception, the NBA has issued more than 1,200 permissions for research and commercial exploitation, with a cumulative benefit‑sharing payment of approximately ₹150 crore reported in the 2022‑23 annual report. The State Biodiversity Boards have collectively catalogued over 1.5 million species occurrences in the National Biodiversity Database, enhancing the country’s capacity for ecological monitoring. However, a 2021 audit by the Comptroller and Auditor General highlighted delays in benefit‑sharing disbursements and uneven compliance among SBBs, prompting the Ministry to issue revised guidelines in 2022. Ongoing challenges include harmonising the Act with the 2020 National Biodiversity Strategy and the need for capacity‑building in remote panchayats to ensure effective BMC functioning.

Significance and Impact

The BDA 2002 stands out as one of the few national laws that explicitly integrates access‑and‑benefit‑sharing (ABS) with the protection of indigenous knowledge, influencing similar legislation in Brazil and South Africa. By mandating PIC and MAT, the Act has deterred biopiracy incidents, notably preventing the unlicensed export of the Indian medicinal plant Andrographis paniculata in 2015. Its institutional architecture—NBA, SBBs, and BMCs—has created a multi‑tiered governance model that balances scientific research with community rights. Moreover, the Act’s provisions have spurred private‑sector investment in bio‑based industries, contributing to an estimated US$ 2.3 billion biotechnology market in India by 2024, while ensuring that a share of profits returns to local custodians of biodiversity.